» Articles » PMID: 38752478

DCM-Spheroid Morphs Express PADs and Citrullinated Cytoskeletal Proteins

Overview
Publisher Sage Publications
Specialty Biochemistry
Date 2024 May 16
PMID 38752478
Authors
Affiliations
Soon will be listed here.
Abstract

During investigating the role of peptidylarginine deiminase (PAD) enzymes in dilated cardiomyopathy (DCM), we observed unique spheroid formation in DCM-myofibroblasts that distinguished them from normal cardiac myofibroblasts. The present study aimed to assess the presence of PADs, the extracellular matrix (ECM), and citrullination in DCM spheroids using immunofluorescence staining and imaging techniques. The results revealed that spheroids derived from DCM-myofibroblasts displayed a more distinctive, tightly packed structure compared with those derived from human cardiac fibroblasts. DCM spheroids showed abundant protein expression of the PAD 2, 3, and 4 enzymes. Notably, increased Ki67 protein expression was associated with increased proliferation in DCM spheroids. Cytoskeletal proteins such as Col-1A, vimentin, α-SMA, and F-actin were highly abundant in DCM spheroids. Furthermore, DCM spheroids contained citrullinated cytoskeletal proteins, mainly citrullinated vimentin and citrullinated fibronectin. These observations supported the occurrence of PAD-mediated citrullination of ECM proteins in DCM spheroids. Collectively, these findings describe the distinctive features of DCM spheroids, representing the cellular characteristics of DCM myofibroblasts. Therefore, DCM spheroids can serve as an in vitro model for further investigations of disease morphology and therapeutic efficacy.

References
1.
Hou J, Wen X, Long P, Xiong S, Liu H, Cai L . The role of post-translational modifications in driving abnormal cardiovascular complications at high altitude. Front Cardiovasc Med. 2022; 9:886300. PMC: 9515308. DOI: 10.3389/fcvm.2022.886300. View

2.
Heinrich M, M R H Mostafa A, Morton J, Hawinkels L, Prakash J . Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Adv Drug Deliv Rev. 2021; 174:265-293. DOI: 10.1016/j.addr.2021.04.018. View

3.
Colombo E, Cattaneo M . Multicellular 3D Models to Study Tumour-Stroma Interactions. Int J Mol Sci. 2021; 22(4). PMC: 7915117. DOI: 10.3390/ijms22041633. View

4.
Zanoni M, Cortesi M, Zamagni A, Arienti C, Pignatta S, Tesei A . Modeling neoplastic disease with spheroids and organoids. J Hematol Oncol. 2020; 13(1):97. PMC: 7364537. DOI: 10.1186/s13045-020-00931-0. View

5.
Granato G, Ruocco M, Iaccarino A, Masone S, Cali G, Avagliano A . Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation. Cell Death Discov. 2017; 3:17038. PMC: 5511858. DOI: 10.1038/cddiscovery.2017.38. View